Targeting AKR1B1 reprograms tumor-associated macrophages to enhance antitumor immunity
Background
Tumor-associated macrophages (TAMs) are key drivers of the immunosuppressive tumor microenvironment (TME), thereby limiting the efficacy of immune checkpoint inhibitors (ICIs). However, the underlying mechanisms remain unclear.
Methods
Bot…